Pazopanib Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pazopanib Hydrochloride
Health Canada Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

xyz-pharma-m-2025-02-24

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

xyz-pharma-m-2025-02-24

Contact Supplier

Pazopanib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 13 USDMF, 7 EU WC, 5 KDMF, 9 NDC API, 35 Listed Suppliers, $ API Reference Price

40 API Suppliers
13 USDMF
7 EU WC
5 KDMF
9 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

37 Intermediate Suppliers

37 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers, 7 FDA Orange Book, 4 Europe, 2 Canada, 12 Australia, 2 South Africa, 17 Listed Dossiers

44 FDF Dossiers
7 FDA Orange Book
4 Europe
2 Canada
12 Australia
2 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE
TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 17 Solubilizers, 15 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 11 Film Formers & Plasticizers, 10 Lubricants & Glidants, 8 Parenteral, 6 Co-Processed Excipients, 5 Emulsifying Agents, 5 Topical, 5 Empty Capsules, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents

45 Coating Systems & Additives
28 Fillers, Diluents & Binders
22 Controlled & Modified Release
17 Solubilizers
15 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
13 Granulation
13 Direct Compression
11 Film Formers & Plasticizers
10 Lubricants & Glidants
8 Parenteral
6 Co-Processed Excipients
5 Emulsifying Agents
5 Topical
5 Empty Capsules
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
3 Chewable & Orodispersible Aids
3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 14 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
14 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 10 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

2 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,841 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Gowling WLG (Canada) LLP

02 1Gowlings

filter Patent Reset all filters

2 All

01 22432000

filter Product Reset all filters

2 All

01 2Pazopanib hydrochloride

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 22021-12-19

Product Main Page

01

Gowling WLG (Canada) LLP

Pazopanib Hydrochloride

ESF Europe

Not Confirmed

Gowling WLG (Canada) LLP

Canada

ESF Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-19

Date Granted : 2011-03-15

Pazopanib Hydrochloride

Brand Name : VOTRIENT

Patent Number : 2432000

Filing Date : 2001-12-19

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-19

Date Granted : 2011-03-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowlings

Pazopanib Hydrochloride

ESF Europe

Not Confirmed

Gowlings

Canada

ESF Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-19

Date Granted : 2011-03-15

Pazopanib Hydrochloride

Brand Name : VOTRIENT

Patent Number : 2432000

Filing Date : 2001-12-19

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-19

Date Granted : 2011-03-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!